-
1
-
-
0343660332
-
Lipid metabolism
-
John Wiley and Sons
-
nd-ed., John Wiley and Sons: 1995; pp 662-726.
-
(1995)
nd-Ed.
, pp. 662-726
-
-
Voet, D.1
Voet, J.2
-
2
-
-
0035528772
-
Statins: Mechanism of action and effects
-
Stancu, C.; Sima, A. Statins: mechanism of action and effects. J. Cell. Mol. Med. 2001, 5(4), 378-387.
-
(2001)
J. Cell. Mol. Med.
, vol.5
, Issue.4
, pp. 378-387
-
-
Stancu, C.1
Sima, A.2
-
3
-
-
0037207278
-
Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells
-
Chung, H.K.; Lee, I.K.; Kang, H.; Suh, J.M.; Kim, H.; Park, K.C.; Kim, D.W.; Kim, Y.K.; Ro, H.K.; Shong, M. Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells. Exp Mol. Med. 2002, 34 (6), 451-461.
-
(2002)
Exp Mol. Med.
, vol.34
, Issue.6
, pp. 451-461
-
-
Chung, H.K.1
Lee, I.K.2
Kang, H.3
Suh, J.M.4
Kim, H.5
Park, K.C.6
Kim, D.W.7
Kim, Y.K.8
Ro, H.K.9
Shong, M.10
-
4
-
-
0034533147
-
Statins as a newly recognized type of immunomodulator
-
Kwak, B.; Mulhaupt, F.; Myit, S.; Mach, F. Statins as a newly recognized type of immunomodulator. Nat. Med. 2000, 6 (12), 1399-1402.
-
(2000)
Nat. Med.
, vol.6
, Issue.12
, pp. 1399-1402
-
-
Kwak, B.1
Mulhaupt, F.2
Myit, S.3
Mach, F.4
-
5
-
-
2642521993
-
Statins as immunomodulatory agents
-
Mach, F. Statins as immunomodulatory agents. Circulation 2004, 109 (Suppl II), 15-17.
-
(2004)
Circulation
, vol.109
, Issue.SUPPL. II
, pp. 15-17
-
-
Mach, F.1
-
6
-
-
1342282244
-
A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma
-
McKay, A.; Leung, B.P.; Mc Innes, I.B.; Thomson, N.C.; Liew, F.Y. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J. Immunol. 2004, 172 (5), 2903-2908.
-
(2004)
J. Immunol.
, vol.172
, Issue.5
, pp. 2903-2908
-
-
McKay, A.1
Leung, B.P.2
Mc Innes, I.B.3
Thomson, N.C.4
Liew, F.Y.5
-
7
-
-
1642405502
-
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells
-
Mulhaupt, F.; Matter, C.M.; Kwak, B.R.; Pelli, G.; Veillard, N.R.; Burger, F.; Graber, P.; Luscher, T.F.; Mach, F. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc. Res. 2003, 59 (3), 755-766.
-
(2003)
Cardiovasc. Res.
, vol.59
, Issue.3
, pp. 755-766
-
-
Mulhaupt, F.1
Matter, C.M.2
Kwak, B.R.3
Pelli, G.4
Veillard, N.R.5
Burger, F.6
Graber, P.7
Luscher, T.F.8
Mach, F.9
-
8
-
-
0037038402
-
The HMG-CoA reductase inhibitor atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
-
Youssef, S.; Stuve, O.; Patarroyo, J.C.; Ruiz, P.J.; Radosevich, J.L.; Hur, E.M.; Bravo, M.; Mitchell, D.J.; Sobel, R.A.; Steinman, L.; Zamvil, S.S. The HMG-CoA reductase Inhibitor atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002, 420 (6911), 78-84.
-
(2002)
Nature
, vol.420
, Issue.6911
, pp. 78-84
-
-
Youssef, S.1
Stuve, O.2
Patarroyo, J.C.3
Ruiz, P.J.4
Radosevich, J.L.5
Hur, E.M.6
Bravo, M.7
Mitchell, D.J.8
Sobel, R.A.9
Steinman, L.10
Zamvil, S.S.11
-
9
-
-
0037309378
-
A novel anti-inflammatory role of simvastatin in inflammatory arthritis
-
Leung, B.P.; Sattar, N.; Crilly, A.; Prach, M.; McCarey, D.W.; Payne, H.; Madhok, R.; Gracie, J.A.; Liew, F.Y.; McInnes, I.B. A novel anti-inflammatory role of simvastatin in inflammatory arthritis. J. Immunol. 2003, 170 (3), 1524-1530.
-
(2003)
J. Immunol.
, vol.170
, Issue.3
, pp. 1524-1530
-
-
Leung, B.P.1
Sattar, N.2
Crilly, A.3
Prach, M.4
McCarey, D.W.5
Payne, H.6
Madhok, R.7
Gracie, J.A.8
Liew, F.Y.9
McInnes, I.B.10
-
10
-
-
0034671075
-
Impact and management of hyperlipidemia post-transplantation
-
Fellstrom, B. Impact and management of hyperlipidemia post-transplantation. Transplantation 2000, 70 (11 Suppl), 51-57.
-
(2000)
Transplantation
, vol.70
, Issue.11 SUPPL.
, pp. 51-57
-
-
Fellstrom, B.1
-
11
-
-
3142570575
-
Variable cyclosporine exposure: A risk factor for chronic allograft nephropathy and graft loss
-
He, X.; Johnston, A. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss. Transplant. Proc. 2004, 36 (5), 1321-1326.
-
(2004)
Transplant. Proc.
, vol.36
, Issue.5
, pp. 1321-1326
-
-
He, X.1
Johnston, A.2
-
12
-
-
85087226690
-
Hypercholesterolemia and chronic rejection of renal allografts
-
Blum, C.B. Hypercholesterolemia and chronic rejection of renal allografts. Transplantation 2001, 72 (4), 751-75.
-
(2001)
Transplantation
, vol.72
, Issue.4
, pp. 751-775
-
-
Blum, C.B.1
-
13
-
-
28544440639
-
Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a two year prospective trial
-
Terasaki, P.I.; Ozawa, M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a two year prospective trial. Transplantation 2005, 80 (9), 1194-1197.
-
(2005)
Transplantation
, vol.80
, Issue.9
, pp. 1194-1197
-
-
Terasaki, P.I.1
Ozawa, M.2
-
14
-
-
0022384860
-
Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: Studies with soluble antigens in intact mice
-
Wofsy, D.; Mayes, D.C.; Woodcock, J.; Seaman, W.E. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. J. Immunol. 1985, 135 (3), 1698-1701.
-
(1985)
J. Immunol.
, vol.135
, Issue.3
, pp. 1698-1701
-
-
Wofsy, D.1
Mayes, D.C.2
Woodcock, J.3
Seaman, W.E.4
-
15
-
-
0030953045
-
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences
-
Lennernas, H.; Fager, G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin. Pharmacokinet. 1997, 32 (5), 403-425.
-
(1997)
Clin. Pharmacokinet.
, vol.32
, Issue.5
, pp. 403-425
-
-
Lennernas, H.1
Fager, G.2
-
18
-
-
0030893205
-
Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR
-
Favre, N.; Bordmann, G.; Rudin, W. Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR. J. Immunol. Meth. 1997, 204 (1), 57-66.
-
(1997)
J. Immunol. Meth.
, vol.204
, Issue.1
, pp. 57-66
-
-
Favre, N.1
Bordmann, G.2
Rudin, W.3
-
19
-
-
0032543306
-
The role of T-cell costimulatory activation pathways in transplant rejection
-
Sayegh, M.H.; Turka, L. The role of T-cell costimulatory activation pathways in transplant rejection. N. Engl. J. Med. 1998, 338 (25), 1813-1821.
-
(1998)
N. Engl. J. Med.
, vol.338
, Issue.25
, pp. 1813-1821
-
-
Sayegh, M.H.1
Turka, L.2
-
20
-
-
0344013648
-
Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development
-
Hakamada, R.; Uehara, Y.; Kuribayashi, K.; Numabe, A.; Saito, K.; Negoro, H.; Fujita, T.; Toyo-oka, T.; Kato, T. Inhibition of hydroxymethylglutaryl- coenzyme a reductase reduces Th1 development and promotes Th2 development. Cir. Res. 2003, 93 (10), 948-956.
-
(2003)
Cir. Res.
, vol.93
, Issue.10
, pp. 948-956
-
-
Hakamada, R.1
Uehara, Y.2
Kuribayashi, K.3
Numabe, A.4
Saito, K.5
Negoro, H.6
Fujita, T.7
Toyo-oka, T.8
Kato, T.9
|